Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA

Detalles Bibliográficos
Autores principales: Vojinovic, J, Furlan, A, Damjanov, N, D’Urzo, C, Dinarello, CA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194520/
http://dx.doi.org/10.1186/1546-0096-9-S1-P166
_version_ 1782213990565281792
author Vojinovic, J
Furlan, A
Damjanov, N
D’Urzo, C
Dinarello, CA
author_facet Vojinovic, J
Furlan, A
Damjanov, N
D’Urzo, C
Dinarello, CA
author_sort Vojinovic, J
collection PubMed
description
format Online
Article
Text
id pubmed-3194520
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31945202011-10-18 Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA Vojinovic, J Furlan, A Damjanov, N D’Urzo, C Dinarello, CA Pediatr Rheumatol Online J Poster Presentation BioMed Central 2011-09-14 /pmc/articles/PMC3194520/ http://dx.doi.org/10.1186/1546-0096-9-S1-P166 Text en Copyright ©2011 Vojinovic et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Vojinovic, J
Furlan, A
Damjanov, N
D’Urzo, C
Dinarello, CA
Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
title Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
title_full Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
title_fullStr Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
title_full_unstemmed Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
title_short Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
title_sort epigenetic modulation with oral histone deacetylase (hdac) inhibitor as a new treatment option in jia
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194520/
http://dx.doi.org/10.1186/1546-0096-9-S1-P166
work_keys_str_mv AT vojinovicj epigeneticmodulationwithoralhistonedeacetylasehdacinhibitorasanewtreatmentoptioninjia
AT furlana epigeneticmodulationwithoralhistonedeacetylasehdacinhibitorasanewtreatmentoptioninjia
AT damjanovn epigeneticmodulationwithoralhistonedeacetylasehdacinhibitorasanewtreatmentoptioninjia
AT durzoc epigeneticmodulationwithoralhistonedeacetylasehdacinhibitorasanewtreatmentoptioninjia
AT dinarelloca epigeneticmodulationwithoralhistonedeacetylasehdacinhibitorasanewtreatmentoptioninjia

Ejemplares similares